Drugs / SC-PEG E. coli L-asparaginase
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01225874 | Dec 1999 → Mar 2006 | leukemia | Children's Oncology Group | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SC-PEG E. coli L-asparaginase | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01225874 ↗ |
| Route | Intramuscular | “IM SC-PEG E. coli asparaginase on days 2, 5, 8, 12, 15, and 19” NCT01225874 ↗ |